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1. Introduction 
The raccoon roundworm, Baylisascaris procyonis, is classified under the Phylum 
Nemathelminthes (the roundworms) and Class Nematoda. It is a member of Family 
Ascaridae and Superfamily Ascaridoidea, which represents intestinal worms with direct life 
cycles. Other, more familiar ascarids are Ascaris lumbricoides,Toxocara canis, and Toxocara cati, 
nematode parasites of humans, dogs, and cats, respectively. 
Baylisascaris procyonis was first named as Ascaris columnaris and isolated from raccoons in the 
New York Zoological Park in 1931(McClure, 1933). It was later recognized as a different 
species (Ascaris procyonis) in raccoons in Europe (Stefanski & Zarnowski, 1951). The genus 
Baylisascaris was defined by Sprent in 1968 and included eight recognized and two 
provisional species previously classified as members of theAscaris or Toxascaris genus 
(Sprent, 1968). The new genus was namedafter H. A. Baylis, formerly member of the British 
Museum of Natural History, London, United Kingdom.The possibility of human infection 
was anticipated by Beaver (Beaver, 1969) and later by Kazacos (Kazacos& Boyce, 1989). The 
marked zoonotic potential of B. procyonis has become apparent only in the last 2 decades. 
The first confirmed cases of NLM in humans were described to have occurred in two young 
boys, in 1984 and 1985 (Huff et al., 1984; Fox et al., 1985).  
This parasite is common in raccoons (Procyon lotor) in North America and Europe and also is 
frequent in racoons kept in zoos or peltry farms. Other members of this genus are found in 
bears, skunks, badgers and other carnivores. There is also evidence that dogs can acquire 
patent B. procyonis infections after scavenging intermediate, hosts. 
Baylisascaris procyonis is considered the most common cause of clinical larva migrans (LM) in 
animals, in which it is usually associated with fatal or severe neurological disease. In 
humans, particularly children, has emerged in recent years as one of the most serious causes 
of zoonotic visceral, ocular, and neural LM (VLM; OLM; NLM) and has been recognized as 
a source of severe, often fatal, neurologic disease. 
2. Morphology and life cycle 
B. procyonis biologically and morphologically resembles the intestinal roundwormof dogs 
Toxocara canis. Adult worms measure are tan-white in color, cylindrical and tapered at both 
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ends. The female reaching 20–22 cm long and the male 9–11 cm long (Kazacos, 2001). 
Cervical alae are vestigial and inconspicuous, the vulva is located one-fourth to one-third 
the body length fromthe anterior end, and males possess pericloacal roughened áreas. The 
egg itself is a typical ascarid egg, although smaller than a Toxocara canis egg, with a thick 
pitted shell and a large, dark zygote that almost completely fills the shell.The eggs of B. 
procyonis are ellipsoidal in shape, brown in color, and have a thickshell with a finely 
granular surface; theyrange in size from 63–88 x 50—70 μm, with most averaging 68–76 x 
55–61 μm. 
Adult female worms in the small intestine of raccoons and produce between 115,000 and 
179,000 eggs/worm/day. In nature, infected raccoons shed an average of 20,000 to 26,000 
eggs per gram of feces, with higher shedding rates in juvenile raccoons than in adults, and 
can shed in excess of 250,000 eggs per gram of feces. Thus, infected raccoons can shed 
millions of B. procyonis eggs daily, leading to widespread and heavy environmental 
contamination.  The numbers of eggs produced by infected raccoons combined with their 
defecation behaviour, ensures that latrine sites will become heavily contaminated. The eggs 
possess a sticky proteinaceous outer coat that enables them to adhere to objects and 
facilitates transmission. B. procyonis eggs become infective (secondstagelarva) in ∼2–4 
weeks, depending on environmental temperature and moisture. B. procyonis eggs are very 
resistant to environmental conditions, especially in moist soil. Although they can be killed 
eventually by extreme heat and dryness, the eggs survive harsh winters, and under 
appropriate conditions, they can remain viable for years, contributing to the long-term 
danger posed by latrines. 
Young raccoons become infected by ingesting infective eggs, whereas older raccoons 
become infected byingesting third-stage larvae (L3’s) in paratecnic hosts, usually rodents. 
Young raccoons become infected at an early age by ingesting eggs fromtheir mother’s 
contaminated teats or fur, from the contaminated den, or from raccoon latrines near their 
den. 
In young raccoons, larvae hatching from eggs enter themucosa of the small intestine and 
develop there several weeks before reentering the intestinal lumen to mature, the worms 
reaching patency in 50–76 days. In older raccoons, larvae from intermediate hosts develop to 
adults in the intestinal lumen, reaching patency in 32–38 days. 
The higherparasite burden of juvenile raccoons (mean burden, 48 to 62 worms) than in 
adults (mean burden, 12 to 22 worms) likely reflects differences in mechanisms of infection. 
Like other parasite (Toxocara spp.) B. procyonis can be borne by intermediate hosts when eggs 
are swallowed by a different vertebrate. Most commonly the intermediate host is a rodent, 
birds or lagomorph. In these animals, parasite eggs hatch in the small intestine, penetrate 
the intestinal wall and are get to the bloodstream through the liver to the lungs, where they 
are eventually distributed via the blood to various organs. Larvae eventually become 
encapsulated within eosinophilic granulomas, where they remain viable until they are 
ingested by raccoonsor for the lifetime of the host (Kazacos& Boyce, 1989). 
B. procyonis larvae often invading the central nevous system (CNS). Invasion of the brain 
seems to be particularly common in rodents, rabbits, birds and primates. In mice, 
approximately 5-7% of B. procyonis larvae are estimated to enter the CNS. These larvae can 
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cause considerable damage, both from mechanical damage during migration and from the 
inflammatory reaction they stimulate. Larvae in the eye can damage the retina and other 
structures. Eventually the larvae encyst, mainly in the connective tissues and muscles. 
 
 
Fig. 1. Life cycle of Baylisascaris procyonis. 
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Humans are accidental intermediate hosts and infection typically occurs in young children 
with pica or geophagia after ingestion of infective B. procyonis eggs from environments or 
items contaminated with raccoon feces (Kazacos, 2000). 
In humans, B. procyonis larvae have a tendency to invade the eyes, spinal cord, and brain, 
causing inflammatory reactions and tissue damage. The result can be blindness, 
neurological damage, and even death. B. procyonis infection typically results in fatal disease 
or severe sequelae. 
3. Epidemiology 
Raccoons, which are the definitive hosts for B. procyonis, are native to the Americas, where 
they can be found from Canada to Panama. They were introduced into Europe, the former 
U.S.S.R. and Asia for the commercial fur trade and into Japan as pets, and have become 
naturalized in some of these areas. The prevalence of B. procyonis infection is high in wild 
raccoons in Germany and those kept in zoos or as pets in Japan (Baeur &Gey, 2002; Kazacos, 
2001; Miyashita,1993; Sato et al., 2001). Although surveys of feral raccoons in Japan have not 
detected this organism, it is possible that some pets released into the wild were infected. 
In areas where B. procyonis is common in raccoons, it has much higher prevalence in juvenile 
raccoons (> 90%) than in adults (37%–55%). Average parasite intensity ranges from 43 to 52 
worms, with juvenile raccoons having a higher mean intensity (48–62, range 1–480) than 
adult raccoons (12–22, range1–257) (Snyder & Fitzgerald 1985; Ermer& Fodge 1986; Kazacos, 
2001). 
In United State B. procyonis roundworms are most prevalent in the midwestern, 
northeastern, and Pacific western states. Numerous surveillance studies have been 
conducted in the southeastern United States, and parasite are most common in the 
mountainous regions of Virginia, Kentucky, and West Virginia (Kazacos, 2001; Souza et al., 
2009). Geographic expansion of B. procyonis  roundwormshas been recently documented in 
Georgia (Eberhard et al., 2003; Blizzard et al., 2010a) and into northwestern and 
southeastern of Florida (Blizzard et al., 2010b).Recently, and study about the prevalence of 
B. procyonis in raccoons in Portland, Oregon, showed that 58% of sampled raccoons were 
found to be infected with parasite (Yeitz et al., 2009). 
In Canada, the prevalence of B. procyonis was estimated in 37.1% of the urban raccoon 
population of Winnipeg (Manitoba) (Sexsmith et al., 2009).  
In most areas where raccoons occur, there should be no environmental limitationson the 
presence of B. procyonis, although conditions for optimal egg development and survival 
willvary based on temperature and humidity. Baylisascaris procyonis eggs become infective in 
11–14 days at 22°C–25° C and 100% humidity (Sakla et al. 1989), similar to eggs of B. 
columnaris (11–16 d) (Berry, 1985). Under natural conditions, with cooler and/or fluctuating 
temperatures, egg development will beslower and will take several weeks to months. 
Under sufficiently warm but fluctuating temperaturas (e.g., cooler nights), most eggs should 
reach infectivity in 3–4+ weeks. Embryonated B. procyonis eggs stored 9–12 years at4° C 
retained their infectivity and central nervous system pathogenicity for mice (Kazacos, 2001). 
Given adequate moisture, embryonated eggs will last years in the soil, including through 
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harsh winters(Kazacos 1986, 1991; Kazacos & Boyce 1989).Conditions of extreme heat and 
dryness, as occur inbarn lofts and attics in summer months, will kill B. procyoniseggs by 
desiccation, probably in a few weeks ormonths (Kazacos & Boyce 1989). 
The epidemiology of Baylisascaris infection is linked to the defecation habits of raccoons. 
Presumably for communication or territorial reasons, individuals and groups of raccoons 
habitually defecate in focal areas called “latrines”, where large amounts of feces and B. 
procyonis eggs accumulate (Kazacos, 2001; Roussere et al., 2003; Page et al., 1998; Page et al., 
1999). Raccoon latrines are found directly on the ground, particularly at the base of trees; 
along and on the tops of fences; on roofs, decks, and stored firewood; and in outbuildings, 
attics, and various other locations (Kazacos, 2001; Roussere et al., 2003; Page et al., 1998). 
Homeowners are often unaware that there are latrines on roofs or hidden elsewhere on their 
property, thus increasing the risk of exposure to raccoon feces. Moreover, decomposition of 
the feces can occur rapidly under outdoor conditions, making it less obvious that these areas 
are contaminated. 
The primary risk factors for human B. procyonis infection include contact with raccoon 
latrines, pica/geophagia, young age (<4 years), and male sex. Older persons who have pica 
or exhibit geophagia are alsoat risk for significant infection. People are commonly exposed 
to the eggsof this parasite in peridomestic areas where infected raccoons are common. 
4. Pathology 
4.1 Infections in humans  
Baylisascaris procyonis causes neurologic disease in wild, zoo, and domestic animals as well 
as human beings. The full clinical spectrum of human baylisascariasis is unknown but 
includes VLM, NLM, and OLM. In addition, preliminary evidence suggests that 
asymptomatic infection also occurs.  
The severity of CNS disease is related to the number of eggs ingested, the extent and 
location of larval migration, and the severity of ensuing inflammation and necrosis (Kazacos 
2000, 2001).When infective B. procyonis eggs are ingested, infective larvae emerge from the 
eggs, penetrate the gut, and after migrating through the liver and lungs, become distributed 
via the bloodstream to various somatic tissues, including skeletal muscles, the viscera, brain, 
and eyes; here, they continue to migrate and eventually become encapsulated in granulomas 
(Kazacos, 1997, 2001). The pathogenicity of the larvae is related to their aggressive migratory 
behavior in the tissues and the fact that they molt and grow considerably during migration 
(Kazacos, 1997, 2000, 2001; Goldberg et al., 1993). Only 5%–7% of ingested larvae enter the 
CNS (Kazacos, 2000, 2001); thus, although theyare not neurotropic per se, their large size, 
aggressive migration, and stimulation of intense eosinophilic inflammatory reactions cause 
extensive damage to nervous (and ocular) tissues (Kazacos, 1997). Baylisascaris larvae 
entering the brain migrate there for extended periods before becoming walled off by host 
reactions.In heavy infections, the brain undergoes postinflammatory atrophy, leading to the 
progressive neurologic impairment and severe incapacitation seen in surviving patients 
with neural LM (Gavin et al., 2002a; Rowley et al., 2000a). Pathologic changes are further 
exacerbated by diagnostic and treatment delays. 
The incubation period in humans is uncertain, but NLM may occur as soon as 2 to 4 weeks 
after ingestion of the eggs. 
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NLM occurs when the parasites migrate through the CNS, and the symptoms vary with the 
location and number of the migrating larvae. The initial signs may be mild, with subtle 
behavioral changes, lethargy, somnolence or irritability, weakness, speech defects and/or 
mild changes in vision, but they can rapidly become severe. A variety of symptoms 
including ataxia, paresis or paralysis, developmental regression, tremors, torticollis, 
nystagmus and coma have been reported. Seizures are common and can be severe. Ocular 
signs, including blindness, also occur in many cases. 
NLM is associated with eosinophilic meningoencephalitis, an elevated peripheral 
cerebrospinal fluid eosinophilia can be detected in cases of meningoencephalitis. 
Some cases of NLM are fatal, almost all surviving patients have been left with serious 
neurological defects despite treatment. It has been reported only a one case of a child who 
developed relatively mild symptoms (headache, right arm pain, vomiting, mild upper 
extremity tremors and dysmetria, progressing to ataxia) and appeared to recover 
completely. 
OLM has been reported more frequently than neural larva migrans, and can occur without 
neurological signs. Inflammatory and degenerative changes are mainly seen in the retina 
and optic disk, usually only in one eye. The clinical signs may include transient obscuration 
of the vision, photophobia, other signs of diffuse unilateral subacute neuroretinitis (DUSN) 
and loss of vision. Some visual defects can be permanent. 
VLM by B. procyonis showed non-specific signs such as low-grade fever, nausea and 
lethargy. Invasion of the liver can result in hepatomegaly, and migration through the lung 
may cause symptoms of pneumonitis. A macular rash, seen mainly on the face and trunk, 
has also been reported. VLM is associated with eosinophilic cardiac pseudotumors (cardiac 
myofibroblastic tumors with high percentage of eosinophils). Subclinical cases might also 
occur in infection with B. procyonis. 
Human infections with B. procyonis have been documented most often in the U.S., but 
suspected cases have been reported from Europe, and a patient with neural larva migrans 
was reported in Canada in 2009. One case of ocular larva migrans in Brazil was reported as a 
probable B. procyonis infection, but the identification was not definitive. No exposure to 
raccoons was documented in the latter case, although the patient had been exposed to 
skunks.  
Other Baylisascaris species have been less well studied, but probably occur in most areas 
where their definitive hosts are found. 
 
Year of 
published 
report 
Location Age Sex Clinical Risk factor 
Diagnostic 
method 
Treatment Outcome 
1975 Missouri 18 mo Female 
Eosinophilic 
meningo-
encephalitis 
Geophagia 
Serologic 
(cross- 
reacting) 
 
Persistent 
weakness and 
spastic right 
arm and leg 
1984 Pennsylvania 10 mo Male 
Eosinophilic 
meningo-
encephalitis 
Pica 
Autopsy, 
serologic 
None Death 
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Year of 
published 
report 
Location Age Sex Clinical Risk factor 
Diagnostic 
method 
Treatment Outcome 
1985 Illinois 18 mo Male 
Eosinophilic 
meningo-
encephalitis 
Down 
syndrome and 
pica 
Autopsy, 
serologic 
Thiabendazole Death 
1991 Germany 48 y Female 
Diffuse 
unilateral 
subacute 
neuroretinitis 
   Ocular sequelae 
1992 California 29y Male 
Diffuse 
unilateral 
subacute 
neuroretinitis 
Exposure to 
raccoons 
Serologic None Ocular sequelae 
1993 Michigan 9 mo Male  Pica Serologic Not recorded 
Neurologic 
deficits, cortical 
blindness 
1994 Oregon 21 y Male Encephalopthy 
Developmental 
delay, 
pica/geophagia 
 Not recorded 
Persistent 
residual deficits 
1994 New York 13 mo Male 
Eosinophilic 
meningo-
encephalitis 
Pica Serologic 
Thiabendazole, 
ivermectin, 
and prednisone 
Neurologic 
deficits, cortical 
blindness, brain 
atrophy 
1995 Massachusetts 10 y Male 
Eosinophilic 
cardiac 
pseudotumor 
Not date Not date None Death 
2000 California 11 mo Male 
Eosinophilic 
encephalitis 
Pica Serologic 
Albendazole 
and 
Methyl-
prednisolone 
Neurologic 
deficits, 
seizures, 
profound visual 
impairment 
2000 California 13 mo Male 
Eosinophilic 
meningo-
encephalitis 
Pica/ 
geophagia 
Brain 
biopsy, 
serologic 
Solumedrol and 
prednisolone 
Neurologic 
deficits, 
blindness, 
seizures, brain 
atrophy 
2001 Minnesota 13 mo Male 
Eosinophilic 
meningo-
encephalitis 
Unknown Serologic 
Methyl-
prednisolone, 
vincristine, and 
thioguanine 
Death 
2001 Minnesota 19 mo Male 
Eosinophilic 
meningo-
encephalitis 
Klinefelter 
síndrome 
Serologic 
Prednisone, 
vincristine, and 
thioguanine 
Death 
2002 California 17 y Male 
Eosinophilic 
meningo-
encephalitis 
Developmental 
delay and 
geophagia 
Brain 
biopsy, 
serologic 
Albendazole 
and 
antiinflammato
ries 
Death 
2002 California 11 mo Male 
Eosinophilic 
meningo-
encephalitis 
Pica/ 
geophagia 
Serologic 
Albendazole 
and 
antiinflammato
ries 
Neurologic 
deficits, cortical 
blindness, 
seizures 
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Year of 
published 
report 
Location Age Sex Clinical Risk factor 
Diagnostic 
method 
Treatment Outcome 
2002 Illinois 2.5 y Male 
Progressive 
encephalo-
pathy 
Pica/ 
geophagia 
Serologic 
Albendazole 
and solumedrol 
Neurologic 
deficits, 
blindness, 
generalized 
spasticity 
2002 Illinois 6 y Male 
Progressive 
encephalopathy
, diffuse 
unilateral 
subacute 
neuroretinitis 
Developmental 
delay,pica/ 
geophagia 
Serologic 
Albendazole 
and prednisone 
Neurologic 
deficits, 
seizures 
2003 Michigan 6 y Male 
Diffuse 
unilateral 
subacute 
neuroretinitis, 
neurologic 
deficits 
Pica Serologic  
Severe 
neurologic 
sequelae 
2003 Michigan 2 y Male 
Eosinophilic 
meningo-
encephalitis, 
chorioretinitis 
Pica Serologic  
Severe 
neurologic 
sequelae 
2004 Louisiana 4 y Male 
Eosinophilic 
meningitis 
Raccoons in  
neighborhood 
Serologic 
Dexamethasone 
albendazole 
Full recovery 
2009 Oregon 17 y Male 
Eosinophilic 
meningo-
encephalitis 
Geophagia and 
substance 
abuse 
Serologic 
Methyl-
prednisolone 
Aphasia and 
memory 
deficits 
2009 Toronto 7 y Male 
Eosinophilic 
meningo-
encephailitis 
Autism, 
raccoons in  
backyard 
Serologic 
Albendazole, 
methyl-
prednisone, 
prednisone 
No longer used 
speech to 
communicate, 
cortical visual 
impairment, 
seizure 
disorder 
2010 New York 12 mo Male 
Eosinophilic 
encephalo-
myelitis 
Geophagia Serologic 
Albendazole, 
prednisone and 
methyl-
prednisolone 
Neurologic 
deficits 
Table 1. Reported human cases caused by Baylisascaris procyonis. 
4.2 Infections in animals 
Susceptibility to Baylisascaris larva migrans varies among animal groups and species (Wirtz 
1982; Sheppard & Kazacos 1997). Animal groups particularly susceptible to parasite NLM 
include rodents, rabbits, primates, and birds, based on the number of cases and species 
affected.  For example, in 2007 a Baylisascaris procyonis infection in a Moluccan cockatoo 
(Cacatua moluccensis), was reported. An adult female Moluccan cockatoo was evaluated for a 
10-day history of progressive ataxia and weakness. The bird had been exposed 
intermittently over a 3-day period to a cage that had previously housed juvenile raccoons. 
Results of diagnostic tests were inconclusive and, despite supportive care, the bird died 7 
days after the initial presentation. Histopathologic examination revealed a single nematode 
larva in the midbrain that was consistent with Baylisascaris species and multifocal 
granulomas in the left ventricle of the heart (Wolf et al., 2007). 
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Some animal groups and species are only marginally susceptible, with limited migration 
occurring in the intestinal wall or viscera; others appear to be resistant. For example, no 
cases of B. procyonis NLM have been documented in opossums, which are commonly 
exposed through foraging at raccoon latrines(Page et al., 1998, 1999), or in adult domestic 
livestockor zoo hoofstock, which are commonly exposed through contaminated hay. Very 
limited or no migration was seen in sheep, goats, and swine experimentally infected with B. 
procyonis (Dubey, 1982; Snyder, 1983; Kazacos & Kazacos 1984). No cases have been 
documented in cats or raptors, which eat rodents possibly contaminated with eggs and/or 
containing L3’s. (Kazacos,  2001). The apparent species limitations to Baylisascaris infection 
should be regarded with caution. 
Except in very heavy infections with intestinal obstruction, raccoons infected with B. 
procyonis appear clinically normal with no outward signs of infection. Similarly, other 
species with Baylisascaris larva migrans usually are asymptomatic if no larvae enter the 
brain. The severity and progression of central nervous system disease in NLM depends on 
the number of eggs ingested, the number of larvae entering the brain, the location and 
extent of migration damage and inflammation in the brain, and the size of the brain.Thus, 
clinical disease will vary from mild, insidious, slowly progressive central nervous system 
disease with subtle clinical signs to acute, fulminating, rapidly progressive central nervous 
system disease with marked clinical signs. Although larvae enter the somatic tissues, eyes, 
and brain of some species as early as 3 days postinfection, clinical central nervous system 
disease is not usually apparent before 9–10 days postinfection, and in many cases not until 
2–4+ weeks postinfection, due to the lag time in causing central nervous system damage and 
inflammation (Kazacos, 1997; Sheppard& Kazacos, 1997). 
5. Diagnostic 
The diagnosis of baylisascariasis is difficult in live patients; there is no widely available, 
non-invasive definitive test. The combination of encephalopathy with cerebrospinal fluid 
(CSF) and peripheral eosinophilia and diffuse white matter disease on neuroimaging, with 
or without eye disease, in a patient from North America or Europe should strongly suggest 
the diagnosis of Baylisascaris NLM, and a history of exposure to raccoons or their feces 
should be sought. 
Unless a brain biopsy is done and a larva is found, antemortem diagnosis usually depends 
on serology, with supportive evidence from other tests.  
5.1 Serology 
In neural larva migrans, antibodies to Baylisascaris can be found in serum and CSF; a rising 
titer is usually seen. An enzyme linked immunosorbent assay (ELISA), indirect 
immunofluorescence and immunoblotting (Western blotting) have been developed to detect 
anti-Baylisascaris antibodies. These serological assays are not commercially available, but 
they may be provided by university research laboratories. In the U.S., an ELISA is available 
from the Department of Comparative Pathobiology at Purdue University, West Lafayette, 
IN. Indirect immunofluorescence tests use frozen sections of B. procyonis third-stage larvae 
as an antigen. Enzyme-linked immunosorbent assay and Western blotting use excretory-
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secretory products from in vitro cultures of B. procyonis larvae as the antigen (Boyce et al., 
1989). Larval excretory-secretory antigens have been characterized as complex 
glycoproteins, with molecular masses of 10 kDa to 200 kDa, that contain several different 
sugar residues(Boyce et al, 1989). Protein epitopes of 33-kDa to 45-kDa antigens appear to be 
recognized selectively by antibodies from B. procyonis-infected humans and animals but not 
by normal human or T. canis antibody-positive sera (Boyce et al, 1989). In addition, children 
with clinical B. procyonis NLM are strongly positive for anti-Baylisascaris antibodies in CSF 
and serum and have consistently been negative for anti-Toxocara antibodies (Cunningham et 
al., 1994; Fox et al., 1985; Gavin et al., 2002; Kazacos, 2001; Moertel et al., 2001; Murray, 2002; 
Park et al., 2000; Rowley et al., 2000). In several of these cases, positive B. procyonis serology 
was confirmed by brain biopsy or at autopsy (CDC, 2002; Fox et al., 1985; Huff et al., 1984; 
Rowley et al., 2000). Acute and convalescent-phase titers characteristically demonstrate 
several fold increases in both serum and CSF anti-Baylisascaris antibody levels (Gavin et al., 
2002; Moertel et al., 2001). 
Although B. procyonis excretory-secretory (BPES) antigen-based ELISA and Western blot 
assays are useful in the immunodiagnosis of this infection, cross-reactivity remains a 
major problem. Recently, a recombinant B. procyonis antigen, BpRAG1, was reported for 
use in development of improved serological assays for the diagnosis of Baylisascaris larva 
migrans (Dangoudoubiyam et al., 2010). In a recent study, authors tested a total of 384 
human patient serum samples in a BpRAG1 ELISA, including 20 patients with clinical 
Baylisascaris larva migrans, 137 patients with other parasitic infections (8 helminth and 4 
protozoan), and 227 with unknown/suspected parasitic infections. A sensitivity of 85% 
and specificity of 86.9% was observed with the BpRAG1 ELISA, compared to only 39.4% 
specificity with the BPES ELISA. In addition, the BpRAG1 ELISA had a low degree 
ofcross-reactivity with antibodies to Toxocara spp. infection (25%), while the BPES antigen 
showed 90.6% cross-reactivity. Based on these results, BpRAG1 antigen has a high degree 
of sensitivity and specificity and should be very useful and reliable in the diagnosis  
and seroepidemiology of Baylisascaris larva migrans by ELISA (Dangoudoubiyam et al., 
2011) 
5.2 Laboratory tests 
Although no routine laboratory test is considered diagnosticof B. procyonis NLM by itself, a 
number of studies provide additional supporting evidence. Most importantly, the presence 
of eosinophilia, particularly eosinophilic meningitis, 
should alert the physician to the possibility of a parasitic etiology(Lo Re& Gluckman, 2003; 
Rothenberg, 1998; Weller, 1993). Eosinophils are not normally present in CSF; their presence 
narrows the differential diagnosis of CNS disease and provides an early or theonly etiologic 
clue. In documented cases of NLM, the peripheral white blood cell count is usually mildly 
elevated, but eosinophilia may be marked. Cerebrospinal fluid cell counts may be normal at 
presentation and generally demonstrate only mild leukocytosis, again with eosinophilia. 
Notably, even in the absence of pleocytosis, demonstrable CSF eosinophilia may be evident. 
Because eosinophils are easily missed in unstained or Gram-stained CSF, it may be 
necessary to request Wright’s orGiemsa stain of cytocentrifuged CSF specimens. In 
documented cases of NLM, CSF protein is generally normal or only mildly elevated, while 
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CSF glucose levels are normal. Although the finding of elevated serum isohemagglutinins, 
caused by cross-reactions between larval glycoproteins and human blood group antigens, is 
not specific for baylisascariasis, it does provide an additional clue to the diagnosis (Boyce et 
al., 1989). 
5.3 Other techniques 
Imaging techniques and encephalography provide supportive evidence and help rule out 
other causes. In ocular larva migrans, an ophthalmoscopic examination may occasionally 
reveal large, motile larvae in the retina, as well as choroidioretinitis and other signs of 
DUSN. The presence of Baylisascaris larvae in the eye is also suggestive in cases with 
neurological signs. Biopsies of the CNS are occasionally definitive, but larvae are often 
absent from the sample. A definitive diagnosis can also be made retrospectively from CNS 
samples taken at autopsy. Baylisascaris larvae are much larger (up to 80 μm in diameter and 
up to 1900 μm long) than Toxocara larvae, and can also be distinguished by their 
morphology. However, parasite larvae can be difficult to identify within tissues, and 
misidentification is common. In tissues, the third stage larvae of B. procyonis cannot be 
differentiated from B. columnaris or B. melis. Epidemiological evidence, such as a history of 
exposure to raccoons but not skunks or badgers, can be suggestive. 
6. Treatment 
The prognosis for B. procyonis NLM is grave with or without treatment; among documented 
cases,there are no neurologically intact survivors. In this parasite is very important early 
clinical suspicion of raccoon roundworm meningoencephalitis. 
The majority of cases have been treated with anthelmintics and corticosteroids. Empirical 
anthelmintic treatment with thiabendazole, fenbendazole, tetramisole, or ivermectin has 
failed to prevent death or unfavorable outcomes. Animal data suggest that albendazole and 
diethylcarbazinehave the best CSF penetration and larvicidal activity (Kazacos, 2001). 
Treatment with albendazole is protective in animal models if eggs have been ingested, but 
symptoms have not yet developed. In humans, albendazole has been used prophylactically 
after exposure to raccoon latrines or other sources of eggs. Whether it is helpful in patients 
with clinical signs is uncertain, because the death of the parasite might worsen the 
inflammation.  
Albendazole appears to have the more favorable pharmacologic profile, with good 
absorption, high serum concentrations of the active metabolite, good penetration across the 
blood-brain barrier, and minimal toxicity (de Silva et al., 1997; Jung et al., 1990). 
Most clinical cases have been treated concurrently with anthelmintics and corticosteroids; 
the corticosteroids are used to suppress inflammation caused by the death of the larvae, as 
well as to dampen the existing inflammatory response. In a recent case a early intervention 
with both, albendazole and steroids, may have contributed to patient’s partial recovery 
(Hajek et al., 2009) and a mild case of suspected B procyonis infection, with apparent early 
complete response after cerebellar edema, was treated with early corticosteroids and later 
albendazole (Pai et al., 2007). 
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Other supportive therapy may also be given. Recently, an acute eosinophilic 
meningoencephalitis, caused by Baylisascaris procyonis in a previously healthy teenager with 
a history of substance abuse, was treated with methylprednisolone; no antihelmintic drugs 
were administered (Chun et al., 2009). 
Laser photocoagulation, systemic corticosteroids and other therapies have been used in 
ocular larva migrans (Goldberg et al., 1993; Kazacos et al., 1985). 
In many cases, significant damage has already occurred by the time treatment is begun, and 
improvement is not seen. The best chance of recovery is expected with a very early 
diagnosis and treatment. 
7. Prevention and control 
In intermediate hosts, the risk of infection can be decreased by avoiding contact with 
raccoons, other definitive hosts and their feces. Raccoons can be discouraged from visiting 
homes and farms with the same measures that are used to prevent disease in humans. 
Infections are difficult to prevent completely in pets allowed outdoors, as the infective eggs 
can survive for long periods in the environment. In dogs, monthly heartworm/nematode 
preventatives appear to decrease the risk of intestinal infection with B. procyonis. In high-risk 
areas, dogs that are not on these preventatives should receive regular fecal examinations to 
decrease the risk that they will shed eggs.  
In zoos and other facilities, the housing for intermediate hosts should be designed to 
minimize exposure to raccoons, skunks and other definitive hosts. Captive raccoons and 
skunks should be kept in dedicated cages that can be cleaned, if necessary, with the harsh 
methods required to destroy Baylisascaris eggs. They should be tested regularly and 
dewormed when necessary, and they should not be fed wild animals that might carry 
larvae. Newly acquired definitive hosts should be quarantined and dewormed. Once 
contamination has occurred, it can be difficult to remove completely. Intermediate hosts in 
exhibits are sometimes treated prophylactically with pyrantel tartrate or ivermectin. 
Similarly to humans, animals with recent exposure might also be treated with albendazole 
to prevent the development of clinical signs. 
In humans, risk of infection is greatest when infants or toddlers with geophagia or pica 
come in contact with raccoon latrines or an environment contaminated by infected raccoon 
feces. Young infants and toddlers, particularly those with pica or geophagia, should be kept 
away from potentially contaminated areas. 
Raccoon latrines in and around homes and play areas shouldbe cleaned up and 
decontaminated. However, the longevity of B. procyonis eggs and their resistance to 
disinfection or decontamination makes successful environmental cleanup difficult. Recently 
a publication (Shafir et al., 2011) showed that eggs survived complete desiccation for at least 
6 months at room temperature. Total loss of viability was observed after 7 months of 
desiccation. Eggs frozen at –15°C for 6 months demonstrated no reduction in viability. 
Freeze–thaw, including exposure to 5 cycles, did not affect survival. Although they did not 
specifically design experiments to assess the effect of chlorine on inactivation of B. procyonis 
eggs, exposure to undiluted household bleach for 90 min toremove the mammillated layer 
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did not affect viability. In this study (Shafir et al., 2011) B. procyonis eggs showed alow 
thermal death point at <62°C, similar to that reported for other ascarids (Shafir et al., 2007; 
Feachem et al., 1983).Heat is by far the best method of killing B. procyonis eggs (Kazacos, 
2001). Boiling water, steam-cleaning, flaming, or fire are highly effective and practical 
methods for decontamination of large or small areas. The use of direct flames from a 
propaneflame-gun is a favored method (Kazacos, 2001). For heavily contaminated areas a 
combination of removal and disposal of the top few inches of surface soil with flaming is 
most effective. 
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insight on zoonosis and both authors and the editor hope that the work compiled in it would help to raise
awareness and interest in this field. It should also help researchers, clinicians and other readers in their
research and clinical usage.
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